The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes
Open accessAbstract
AIM: To review Hepatitis C virus (HCV) prevalence and genotypes distribution worldwide. METHODS: We conducted a systematic study which represents one of the most comprehensive effort to quantify global HCV epidemiology, using the best available published data between 2000 and 2015 from 138 countries (about 90% of the global population), grouped in 20 geographical areas (with the exclusion of Oceania), as defined by the Global Burden of Diseases project (GBD). Countries for which we were unable to obtain HCV genotype prevalence data were excluded from calculations of regional proportions, although their populations were included in the total population size of each region when generating regional genotype prevalence estimates. RESULTS: Total global HCV prevalence is estimated at 2.5% (177.5 million of HCV infected adults), ranging from 2.9% in Africa and 1.3% in Americas, with a global viraemic rate of 67% (118.9 million of HCV RNA positive cases), varying from 64.4% in Asia to 74.8% in Australasia. HCV genotype 1 is the most prevalent worldwide (49.1%), followed by genotype 3 (17.9%), 4 (16.8%) and 2 (11.0%). Genotypes 5 and 6 are responsible for the remaining < 5%. While genotypes 1 and 3 are common worldwide, the largest proportion of genotypes 4 and 5 is in lower-income countries. Although HCV genotypes 1 and 3 infections are the most prevalent globally (67.0% if considered together), other genotypes are found more commonly in lower-income countries where still account for a significant proportion of HCV cases. CONCLUSION: A more precise knowledge of HCV genotype distribution will be helpful to best inform national healthcare models to improve access to new treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
Lauer, G. M., & Walker, B. D. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107053450107 · Cited by 2,973
Mohd Hanafiah, K., Groeger, J., Flaxman, A. D., & Wiersma, S. T. (2013) · Hepatology · doi:10.1002/hep.26141 · Cited by 2,515
Global epidemiology and genotype distribution of the hepatitis C virus infection
Gower, E., Estes, C., Blach, S., Razavi-Shearer, K., & Razavi, H. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.07.027 · Cited by 1,903
Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
Lawitz, E., Mangia, A., Wyles, D., Rodriguez-Torres, M., Hassanein, T., Gordon, S. C., Schultz, M., Davis, M. N., Kayali, Z., Reddy, K. R., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214853 · Cited by 1,788
Global distribution and prevalence of hepatitis C virus genotypes
Messina, J. P., Humphreys, I., Flaxman, A., Brown, A., Cooke, G. S., Pybus, O. G., & Barnes, E. (2015) · Hepatology · doi:10.1002/hep.27259 · Cited by 1,589
The global burden of hepatitis C
Lavanchy, D. (2009) · Liver International · doi:10.1111/j.1478-3231.2008.01934.x · Cited by 1,368
Smith, D. B., Bukh, J., Kuiken, C., Muerhoff, S. A., Rice, C. M., Stapleton, J. T., & Simmonds, P. (2014) · Hepatology · doi:10.1002/hep.26744 · Cited by 1,353
Evolving epidemiology of hepatitis C virus
Lavanchy, D. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03432.x · Cited by 1,318
Disability weights for the Global Burden of Disease 2013 study
Salomon, J. A., Haagsma, J. A., Davis, A., de Noordhout, C. M., Polinder, S., Havelaar, A. H., Cassini, A., Devleesschauwer, B., Kretzschmar, M., Speybroeck, N., et al. (2015) · The Lancet Global Health · doi:10.1016/s2214-109x(15)00069-8 · Cited by 1,217
Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection
Sulkowski, M. S., Gardiner, D. F., Rodriguez-Torres, M., Reddy, K. R., Hassanein, T., Jacobson, I., Lawitz, E., Lok, A. S., Hinestrosa, F., Thuluvath, P. J., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1306218 · Cited by 1,190
The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt
Frank, C., Mohamed, M. K., Strickland, G. T., Lavanchy, D., Arthur, R. R., Magder, L. S., Khoby, T. E., Abdel-Wahab, Y., Ohn, E. S. A., Anwar, W., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(99)06527-7 · Cited by 1,131
Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
Jacobson, I. M., Gordon, S. C., Kowdley, K. V., Yoshida, E. M., Rodriguez-Torres, M., Sulkowski, M. S., Shiffman, M. L., Lawitz, E., Everson, G., Bennett, M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214854 · Cited by 1,090
A proposed system for the nomenclature of hepatitis C viral genotypes
Simmonds, P., Alberti, A., Alter, H. J., Bonino, F., Bradley, D. W., Brechot, C., Brouwer, J. T., Chan, S.-W., Chayama, K., Chen, D.-S., et al. (1994) · Hepatology · doi:10.1002/hep.1840190538 · Cited by 1,023
Davis, G. L., Alter, M. J., El–Serag, H., Poynard, T., & Jennings, L. W. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.09.067 · Cited by 878
Health metrics and evaluation: strengthening the science
Murray, C. J., & Frenk, J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60526-7 · Cited by 849
Denniston, M. M., Jiles, R. B., Drobeniuc, J., Klevens, R. M., Ward, J. W., McQuillan, G. M., & Holmberg, S. D. (2014) · Annals of Internal Medicine · doi:10.7326/m13-1133 · Cited by 724
(2010) · Clinical Infectious Diseases · doi:10.1086/652283 · Cited by 594
Lawitz, E., Poordad, F. F., Pang, P. S., Hyland, R. H., Ding, X., Mo, H., Symonds, W. T., McHutchison, J. G., & Membreno, F. E. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62121-2 · Cited by 547
A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt
Sievert, W., Altraif, I., Razavi, H. A., Abdo, A., Ahmed, E. A., AlOmair, A., Amarapurkar, D., Chen, C., Dou, X., El Khayat, H., et al. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02540.x · Cited by 534
Global Burden of Disease (GBD) for Hepatitis C
The Global Burden of Hepatitis C Working Group (2004) · The Journal of Clinical Pharmacology · doi:10.1177/0091270003258669 · Cited by 488
The changing epidemiology of hepatitis C virus infection in Europe
Esteban, J. I., Sauleda, S., & Quer, J. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.07.033 · Cited by 481
Razavi, H., Waked, I., Sarrazin, C., Myers, R. P., Idilman, R., Calinas, F., Vogel, W., Mendes Correa, M. C., Hézode, C., Lázaro, P., et al. (2014) · Journal of Viral Hepatitis · doi:10.1111/jvh.12248 · Cited by 477
Chronic hepatitis C virus (HCV) disease burden and cost in the United States
Razavi, H., ElKhoury, A. C., Elbasha, E., Estes, C., Pasini, K., Poynard, T., & Kumar, R. (2013) · Hepatology · doi:10.1002/hep.26218 · Cited by 474
A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel
Cornberg, M., Razavi, H. A., Alberti, A., Bernasconi, E., Buti, M., Cooper, C., Dalgard, O., Dillion, J. F., Flisiak, R., Forns, X., et al. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02539.x · Cited by 411
Martin, N. K., Hickman, M., Hutchinson, S. J., Goldberg, D. J., & Vickerman, P. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit296 · Cited by 314
Murphy, D. G., Willems, B., Deschênes, M., Hilzenrat, N., Mousseau, R., & Sabbah, S. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.02366-06 · Cited by 292
The origin of hepatitis C virus genotypes.
Smith, D. B., Yap, P. L., Simmonds, P., Lawlor, E., Power, J., Pathirana, S., & Davidson, F. (1997) · Journal of General Virology · doi:10.1099/0022-1317-78-2-321 · Cited by 284
Historical epidemiology of hepatitis C virus (HCV) in selected countries
Bruggmann, P., Berg, T., Øvrehus, A. L. H., Moreno, C., Brandão Mello, C. E., Roudot‐Thoraval, F., Marinho, R. T., Sherman, M., Ryder, S. D., Sperl, J., et al. (2014) · Journal of Viral Hepatitis · doi:10.1111/jvh.12247 · Cited by 261
Meffre, C., Le Strat, Y., Delarocque‐Astagneau, E., Dubois, F., Antona, D., Lemasson, J., Warszawski, J., Steinmetz, J., Coste, D., Meyer, J., et al. (2010) · Journal of Medical Virology · doi:10.1002/jmv.21734 · Cited by 231
2000 Fleming Lecture. The origin and evolution of hepatitis viruses in humans
Simmonds, P. (2001) · Journal of General Virology · doi:10.1099/0022-1317-82-4-693 · Cited by 219
Genetic History of Hepatitis C Virus in East Asia
Pybus, O. G., Barnes, E., Taggart, R., Lemey, P., Markov, P. V., Rasachak, B., Syhavong, B., Phetsouvanah, R., Sheridan, I., Humphreys, I. S., et al. (2009) · Journal of Virology · doi:10.1128/jvi.01501-08 · Cited by 211
HOPE, V. D., ERAMOVA, I., CAPURRO, D., & DONOGHOE, M. C. (2014) · Epidemiology and Infection · doi:10.1017/s0950268813000940 · Cited by 198
The Global Spread of Hepatitis C Virus 1a and 1b: A Phylodynamic and Phylogeographic Analysis
Magiorkinis, G., Magiorkinis, E., Paraskevis, D., Ho, S. Y. W., Shapiro, B., Pybus, O. G., Allain, J.-P., & Hatzakis, A. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000198 · Cited by 196
Hepatitis C virus (HCV) infection in Africa: a review
Karoney, M. J., & Siika, A. M. (2013) · Pan African Medical Journal · doi:10.11604/pamj.2013.14.44.2199 · Cited by 188
The hepatitis C virus epidemic among injecting drug users
Pybus, O. G., Cochrane, A., Holmes, E. C., & Simmonds, P. (2005) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2004.08.001 · Cited by 162
Historical epidemiology of hepatitis C virus (HCV) in select countries – volume 3
Liakina, V., Hamid, S., Tanaka, J., Olafsson, S., Sharara, A. I., Alavian, S. M., Gheorghe, L., El Hassan, E. S., Abaalkhail, F., Abbas, Z., et al. (2015) · Journal of Viral Hepatitis · doi:10.1111/jvh.12475 · Cited by 158
Hatzakis, A. E., Chulanov, V., Gadano, A. C., Bergin, C. J., Ben‐Ari, Z., Mossong, J., Schréter, I., Baatarkhuu, O., Acharya, S. K., Aho, I., et al. (2015) · Journal of Viral Hepatitis · doi:10.1111/jvh.12351 · Cited by 147
Predicted Effects of Treatment for HCV Infection Vary Among European Countries
Deuffic‐Burban, S., Deltenre, P., Buti, M., Stroffolini, T., Parkes, J., Mühlberger, N., Siebert, U., Moreno, C., Hatzakis, A. E., Rosenberg, W. M., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.05.054 · Cited by 131
Viral hepatitis and the G lobal B urden of D isease: a need to regroup
Cooke, G., Lemoine, M., Thursz, M. R., Gore, C., Swan, T., Kamarulzaman, A., du Cros, P., & Ford, N. P. (2013) · Journal of Viral Hepatitis · doi:10.1111/jvh.12123 · Cited by 122
Widell, A., Shev, S., Månsson, S., Zhang, Y., Foberg, U., Norkrans, G., Frydén, A., Weiland, O., Kurkus, J., & Nordenfelt, E. (1994) · Journal of Medical Virology · doi:10.1002/jmv.1890440311 · Cited by 105
Sequence diversity of hepatitis C virus: Implications for immune control and therapy
Timm, J. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i36.4808 · Cited by 105
Expanding Access to Treatment for Hepatitis C in Resource-Limited Settings: Lessons From HIV/AIDS
Ford, N. P., Singh, K. P., Cooke, G., Mills, E. J., von Schoen-Angerer, T., Kamarulzaman, A., & du Cros, P. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis227 · Cited by 102
de Bruijne, J., Schinkel, J., Prins, M., Koekkoek, S. M., Aronson, S. J., van Ballegooijen, M., Reesink, H. W., Molenkamp, R., & van de Laar, T. J. W. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01146-09 · Cited by 98
Strategies to manage hepatitis C virus infection disease burden – volume 3
Al-Faleh, F. Z., Nugrahini, N., Matičič, M., Tolmane, I., Alzaabi, M. A., Hajarizadeh, B., Valantinas, J., Kim, D. Y., Hunyady, B., Abaalkhail, F. A., et al. (2015) · Journal of Viral Hepatitis · doi:10.1111/jvh.12474 · Cited by 93
Global Burden of Skin Disease as Reflected in Cochrane Database of Systematic Reviews
Karimkhani, C., Boyers, L. N., Prescott, L., Welch, V., Delamere, F. M., Nasser, M., Zaveri, A., Hay, R. J., Vos, T., Murray, C. J. L., et al. (2014) · JAMA Dermatology · doi:10.1001/jamadermatol.2014.709 · Cited by 87
Markov, P. V., van de Laar, T. J. W., Thomas, X. V., Aronson, S. J., Weegink, C. J., van den Berk, G. E. L., Prins, M., Pybus, O. G., & Schinkel, J. (2012) · Journal of Virology · doi:10.1128/jvi.06910-11 · Cited by 68
Sypsa, V., Touloumi, G., Tassopoulos, N., Ketikoglou, I., Vafiadis, I., Hatzis, G., Tsantoulas, D., Akriviadis, E., Delladetsima, J., Demonakou, M., et al. (2004) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2004.00517.x · Cited by 57
Strategies to manage hepatitis C virus ( HCV ) infection disease burden – volume 2
Gane, E. J., Kershenobich, D., Seguin‐Devaux, C., Kristián, P., Aho, I., Dalgård, O., Shestakova, I. V., Nymadawa, P., Blach, S., Acharya, S. K., et al. (2015) · Journal of Viral Hepatitis · doi:10.1111/jvh.12352 · Cited by 55
Kershenobich, D., Razavi, H. A., Cooper, C., Alberti, A., Dusheiko, G. M., Pol, S., Zuckerman, E., Koike, K., Han, K., Wallace, C. M., et al. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02535.x · Cited by 46
Hepatitis C: public health strategies
Lavanchy, D. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80392-4 · Cited by 45
Cited by
Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification
(2021) · Advances in Cancer Research · doi:10.1016/bs.acr.2020.10.001 · Cited by 851
Pimpin, L., Cortez-Pinto, H., Negro, F., Corbould, E., Lazarus, J. V., Webber, L., & Sheron, N. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.05.011 · Cited by 710
Autophagy in liver diseases: A review
Qian, H., Chao, X., Williams, J., Fulte, S., Li, T., Yang, L., & Ding, W.-X. (2021) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2021.100973 · Cited by 373
The changing epidemiology of liver diseases in the Asia–Pacific region
Wong, M. C. S., Huang, J. L. W., George, J., Huang, J., Leung, C., Eslam, M., Chan, H. L. Y., & Ng, S. C. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0055-0 · Cited by 344
Updated epidemiology of gastrointestinal cancers in East Asia
Huang, J., Lucero-Prisno, D. E., Zhang, L., Xu, W., Wong, S. H., Ng, S. C., & Wong, M. C. S. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00726-3 · Cited by 269
Metadata
- Authors
- Petruzziello, A., Marigliano, S., Loquercio, G., Cozzolino, A., & Cacciapuoti, C.
- Venue
- World Journal of Gastroenterology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2016
- Volume
- 22
- Issue
- 34
- Pages
- 7824
- ISSN
- 1007-9327 (ISSN-L)
- OpenAlex
- W2517875316
- Cited by
- 864
- References
- 52
- FWCI
- 60.92
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.